MHC-dependent desensitization of intrinsic anti-self reactivity.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 171, doi. 10.1007/s00262-008-0535-0
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 2
Results: 15
1
2
A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 301, doi. 10.1007/s00262-008-0525-2
- By:
- Publication type:
- Article
3
Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4<sup>+</sup> and CD8<sup>+</sup> T cell epitopes.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 187, doi. 10.1007/s00262-008-0537-y
- By:
- Publication type:
- Article
4
Report on the first international symposium on cancer biology (ISCB), November 14–16, 2007, at the National Institute of Immunology, New Delhi, India.
- Published in:
- 2009
- By:
- Publication type:
- Report
5
A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
6
The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 201, doi. 10.1007/s00262-008-0539-9
- By:
- Publication type:
- Article
7
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 209, doi. 10.1007/s00262-008-0542-1
- By:
- Publication type:
- Article
8
Identification of novel tumor antigens with patient-derived immune-selected antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 221, doi. 10.1007/s00262-008-0543-0
- By:
- Publication type:
- Article
9
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 271, doi. 10.1007/s00262-008-0551-0
- By:
- Publication type:
- Article
10
Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 235, doi. 10.1007/s00262-008-0546-x
- By:
- Publication type:
- Article
11
Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 159, doi. 10.1007/s00262-008-0548-8
- By:
- Publication type:
- Article
12
14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 247, doi. 10.1007/s00262-008-0549-7
- By:
- Publication type:
- Article
13
Topotecan enhances immune clearance of gliomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 259, doi. 10.1007/s00262-008-0550-1
- By:
- Publication type:
- Article
14
Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 281, doi. 10.1007/s00262-008-0552-z
- By:
- Publication type:
- Article
15
NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 291, doi. 10.1007/s00262-008-0554-x
- By:
- Publication type:
- Article